Get startedLog in
    Picture of Actinium Pharmaceuticals logo

    ATNM — Actinium Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSucker Stock
    All News

    Brief: Actinium Announces KOL Webinar to Highlight Recently Announced Iomab-ACT Trial with Leading FDA Approved Commercial CAR T-Cell Therapy Being Led by the University of Texas Southwestern

    Picture of Actinium Pharmaceuticals logoActinium Pharmaceuticals
    07/05/2024 14:07
    May 7 (Reuters) - Actinium Pharmaceuticals Inc  ATNM.A :
    * ACTINIUM ANNOUNCES KOL WEBINAR TO HIGHLIGHT RECENTLY
ANNOUNCED
IOMAB-ACT TRIAL WITH LEADING FDA APPROVED COMMERCIAL CAR T-CELL
THERAPY BEING LED BY THE UNIVERSITY OF TEXAS SOUTHWESTERN

Source text for Eikon:  ID:nPn8Xlm8ca 
Further company coverage:  ATNM.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Actinium Pharmaceuticals

    See all news